Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer
This study has been completed.
National University Hospital, Singapore
Information provided by (Responsible Party):
Haematology-Oncology, National University Hospital, Singapore
First received: September 13, 2005
Last updated: October 31, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2012|
|Primary Completion Date:||April 2007 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Lim YW, Goh BC, Wang LZ, Tan SH, Chuah BY, Lim SE, Iau P, Buhari SA, Chan CW, Sukri NB, Cordero MT, Soo R, Lee SC. Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients. Ann Oncol. 2010 Nov;21(11):2175-82. doi: 10.1093/annonc/mdq230. Epub 2010 Apr 29.